...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
【24h】

Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.

机译:从1960年到2003年,瑞典,丹麦和芬兰的非霍奇金淋巴瘤发病率:

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Reports during the early 1990s indicated non-Hodgkin's lymphoma (NHL) as one of the most rapidly increasing malignancies. More recent trends remain poorly characterized, as do the underlying reasons for NHL time trends, in particular, the effect of changes in classification and registration of lymphoproliferative malignancies. Insights into the descriptive epidemiology of NHL may shed light upon its elusive etiology. METHODS: We used data from the Swedish, Danish, and Finnish national cancer registers to assess the incidences of NHL and other lymphoproliferative malignancies between 1960 and 2004. Using Poisson regression, we estimated the annual rate of change in NHL incidence per decade by sex, age, and country. RESULTS: In Sweden, Denmark, and Finland, the NHL incidence increased in both genders and all age categories by about 4% every year up until the early 1990s. Thereafter, the incidence increased at a slower rate (ages 60-79 years), stabilized (ages 50-59 and > or =80 years), and decreased (ages 0-49 years), respectively, similarly for males and females in the three countries. Time trends of NHL were not reciprocated and explained by trends for other lymphoproliferative malignancies nor explained by trends in NHL as secondary primaries or NHL diagnosed postmortem. CONCLUSIONS: The epidemic increase of NHL has recently subsided. Changes in the classification of lymphoproliferative malignancies, or occurrence of NHL as second primaries, only offer a marginal explanation.
机译:背景:1990年代初期的报道表明,非霍奇金淋巴瘤(NHL)是发展最快的恶性肿瘤之一。 NHL时间趋势的根本原因,尤其是淋巴组织增生性恶性肿瘤的分类和注册改变的影响,仍没有更准确地描述最近的趋势。对NHL的描述性流行病学的见识可能会阐明其难以捉摸的病因。方法:我们使用瑞典,丹麦和芬兰国家癌症登记处的数据评估了1960年至2004年之间NHL和其他淋巴增生性恶性肿瘤的发病率。使用Poisson回归,我们按性别估算了每十年NHL发病率的年变化率,年龄和国家。结果:在瑞典,丹麦和芬兰,直到1990年代初,无论男女,所有年龄段的NHL发病率均以每年约4%的速度增长。此后,男性和女性的发病率分别以较慢的速度增长(60-79岁),稳定(50-59岁且≥80岁)和下降(0-49岁)。三个国家。 NHL的时间趋势没有得到反映,其他淋巴增生性恶性肿瘤的趋势也无法解释,也不能将NHL的继发性原发或NHL诊断的死后趋势加以解释。结论:NHL的流行病近来已经消退。淋巴增生性恶性肿瘤的分类变化,或发生NHL为第二原发性疾病,仅提供了一个很小的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号